|
8:00 am |
Registration and Continental Breakfast |
|
8:45 am |
Welcome and Introduction
Ali K. Abu-Alfa, MD FASN |
|
9:00 am |
Nephrogenic Systemic Fibrosis: An Update
Shawn E.Cowper, MD |
|
9:20 am |
The Clinical Spectrum of NSF
Michael Girardi, MD |
|
9:40 am |
NSF: The Mayo Experience
Christine U. Lee, MD PhD |
|
10:10 am |
RADAR (Research on Adverse Drug Events and Reports)
Overview of NSF: Past, present, and future considerations
Charles L. Bennett, MD PhD |
|
10:30 am |
Panel Discussion
Phillip H. Kuo, MD PhD |
|
10:45 am |
Break |
|
11:00 am |
Link between GCCA and NSF: An Update
Phillip H. Kuo, MD PhD |
|
11:20 am |
Detection of Gadolinium in NSF
Whitney A. High, MD MEng |
|
11:40 am |
Regulation of Circulating Fibrocytes in Fibrosis
Richard H. Gomer, PhD |
|
12:00 am |
Fibrocytes in Pulmonary Fibrosis
Erica L. Herzog, MD PhD |
|
12:20 am |
Panel Discussion
Richard J. Bucala, MD PhD |
|
12:35 pm |
Lunch |
|
1:30 pm |
Impact on the Care of Patients with Renal Disease
Ali K. Abu-Alfa, MD FASN |
|
1:50 pm |
Developing US Strategy for Screening and Risk Reduction
Jeffrey C. Weinreb, MD |
|
2:20 pm |
European Perspective and Experience
Henrik S. Thomsen, MD |
|
2:50 pm |
Panel Discussion
Shawn E. Cowper, MD |
|
3:05 pm |
Break |
|
3:20 pm |
Speaking from the Heart: A Patient Perspective
Jihad Alhariri, MD |
|
3:50 pm |
Discussion and Concluding Remarks
Ali K. Abu-Alfa, MD FASN |
|
4:00 pm |
Adjourn |
.
